Lucia Viganò

Lucia Viganò

UNVERIFIED PROFILE

Are you Lucia Viganò?   Register this Author

Register author
Lucia Viganò

Lucia Viganò

Publications by authors named "Lucia Viganò"

Are you Lucia Viganò?   Register this Author

17Publications

304Reads

29Profile Views

Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.

Colloids Surf B Biointerfaces 2013 Oct 13;110:434-42. Epub 2013 May 13.

Dipartimento di Oncologia Sperimentale e Medicina Molecolare, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.colsurfb.2013.04.022DOI Listing
October 2013

Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine.

J Clin Oncol 2010 Oct 20;28(30):4554-61. Epub 2010 Sep 20.

Montabone Unit for New Drug Development, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto dei Tumori di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.5867DOI Listing
October 2010

The Rorschach test and Gilles de la Tourette's syndrome: a pilot case-control study.

Brain Dev 2009 Oct 28;31(9):657-65. Epub 2008 Nov 28.

Department of Child Neurology and Psychiatry, IRCCS C. Mondino Foundation, University of Pavia, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.braindev.2008.10.003DOI Listing
October 2009

Novel PVA-based hydrogel microparticles for doxorubicin delivery.

Biomacromolecules 2008 Jul 6;9(7):1967-73. Epub 2008 Jun 6.

Dipartimento di Scienze e Tecnologie Chimiche, Universita di Roma Tor Vergata, 000133 Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bm800225vDOI Listing
July 2008

Targeting TRAIL agonistic receptors for cancer therapy.

Clin Cancer Res 2007 Apr;13(8):2313-7

Cristina Gandini Medical Oncology Unit, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-06-2774DOI Listing
April 2007

Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing.

Eur J Cancer 2006 Jan 6;42(2):171-8. Epub 2006 Jan 6.

Istituto Oncologico della Svizzera Italiana, Via Ospedale, 6500 Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2005.09.033DOI Listing
January 2006

Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel.

Clin Cancer Res 2005 Nov;11(22):8097-104

Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1152DOI Listing
November 2005

Diagnostic approach to cerebellar disease in children.

J Child Neurol 2005 Nov;20(11):859-66

Department of Pediatric Neurology, Istituto Neurologico C. Besta, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/08830738050200110101DOI Listing
November 2005

Anthracyclines.

Cancer Chemother Biol Response Modif 2003 ;21:29-40

Division of Medical Oncology A, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
September 2004

Anthracyclines.

Cancer Chemother Biol Response Modif 2002 ;20:59-69

Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
May 2003